{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:47Z","timestamp":1753891127278,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are chronic eosinophilic diseases with serious multisystem manifestations. Patients with HES or EGPA often fail to receive a timely diagnosis, and while these conditions are considered rare, frequent under-recognition indicates that their true prevalence likely exceeds current estimates. Increased primary care physician (PCP) awareness of these systemic eosinophilic conditions and the \u201cred flags\u201d that should trigger referral will help more patients receive timely diagnosis and care. Patients with HES or EGPA present with a heterogeneous range of symptoms and manifestations that can overlap with other conditions, making diagnosis challenging. PCPs should be aware that the following are red flags that warrant further investigation and trigger expert referral: blood eosinophil count \u226510% of total peripheral white blood cells or \u22651,000 cells\/\u03bcL; persistent hypereosinophilia, noting that systemic corticosteroid treatment may variably impact the degree of eosinophilia; refractory asthma symptoms with the need for prolonged or recurrent systemic corticosteroid treatment; reports of decreasing efficacy to asthma therapy; extra-pulmonary findings in the setting of eosinophilia; multiorgan system involvement; and evolving or worsening signs and symptoms over periods of weeks to months or years. PCPs play a key role in the diagnosis and management of rare eosinophilic diseases. By being aware of HES and EGPA and their associated red flags, PCPs are well-placed to recognize these conditions early, trigger further investigations, and coordinate effective multidisciplinary care. This can help patients receive a more accurate diagnosis on time and faster access to treatment, which may ultimately improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fmed.2025.1568770","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:20Z","timestamp":1750742540000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary care physicians play a crucial role in diagnosing and managing rare eosinophilic diseases: HES and EGPA"],"prefix":"10.3389","volume":"12","author":[{"given":"Mili","family":"Shum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ora","family":"Gewurz-Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and international consensus classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali","year":"2024","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.mayocp.2023.02.013","article-title":"HES and EGPA: two sides of the same coin","volume":"98","author":"Khoury","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jaci.2023.03.011","article-title":"Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis","volume":"151","author":"Wechsler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"23743735221143953","DOI":"10.1177\/23743735221143953","article-title":"Insights from social media on the patient experience of living with rare eosinophil-driven diseases","volume":"9","author":"Strobel","year":"2022","journal-title":"J Patient Exp"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s12325-022-02110-8","article-title":"Improving care in eosinophil-associated diseases: a charter","volume":"39","author":"Jackson","year":"2022","journal-title":"Adv Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2024.06.008","article-title":"Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)","volume":"128","author":"Solans-Laque","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejim.2024.08.009","article-title":"Unmasking eosinophilic granulomatosis with polyangiitis (EGPA)","volume":"128","author":"Moroni","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/bor.0000000000000873","article-title":"Therapeutic advances in eosinophilic granulomatosis with polyangiitis","volume":"34","author":"Ford","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/asheducation-2018.1.326","article-title":"Hypereosinophilic syndrome: approach to treatment in the era of precision medicine","volume":"2018","author":"Klion","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13601-019-0277-4","article-title":"Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm","volume":"9","author":"Leru","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-pathmechdis-012419-032756","article-title":"Contributions of eosinophils to human health and disease","volume":"15","author":"Klion","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.3399\/BJGP.2023.0191","article-title":"Exploration of reasons for primary care testing (the why test study): a UK-wide audit using the primary care academic collaborative","volume":"74","author":"Watson","year":"2023","journal-title":"Br J Gen Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1750-1172-2-37","article-title":"Hypereosinophilic syndromes","volume":"2","author":"Roufosse","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/1744666X.2019.1697678","article-title":"Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease","volume":"16","author":"Berti","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fmed.2017.00216","article-title":"(A critical appraisal of) classification of hypereosinophilic disorders","volume":"4","author":"Kahn","year":"2017","journal-title":"Front Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/iid3.495","article-title":"The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom","volume":"9","author":"Requena","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1007\/s10067-021-05783-8","article-title":"Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis","volume":"40","author":"Jakes","year":"2021","journal-title":"Clin Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1193730","DOI":"10.3389\/fonc.2023.1193730","article-title":"The multidisciplinary approach to eosinophilia","volume":"13","author":"Thomsen","year":"2023","journal-title":"Front Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.anai.2023.02.022","article-title":"Hypereosinophilic syndrome in Europe: retrospective study of treatment patterns, clinical manifestations, and healthcare resource utilization","volume":"130","author":"Hwee","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"00912","DOI":"10.1183\/23120541.00912-2023","article-title":"Burden of eosinophilic granulomatosis with polyangiitis in Europe","volume":"10","author":"Jakes","year":"2024","journal-title":"ERJ Open Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jaccas.2020.05.001","article-title":"Eosinophilic granulomatosis with polyangiitis presenting as an acute coronary syndrome","volume":"2","author":"Kolominsky","year":"2020","journal-title":"JACC Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"928192","DOI":"10.3389\/fcvm.2022.928192","article-title":"Case report: an unusual presentation of cardiovascular involvement in eosinophilic granulomatosis with polyangiitis","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.jaip.2018.04.030","article-title":"Consultation for elevated blood eosinophils: clinical presentations, high value diagnostic tests, and treatment options","volume":"6","author":"Khoury","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.anai.2022.08.998","article-title":"Patients\u2019 perspective on the burden of hypereosinophilic syndrome","volume":"129","author":"Silver","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/thorax-2024-BTSabstracts.396","article-title":"The diagnostic journey of patients with eosinophilic granulomatosis with polyangiitis (EGPA) in England: a retrospective observational cohort study","author":"Siddiqui","year":"2024","journal-title":"Thorax"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e027248","DOI":"10.1136\/bmjopen-2018-027248","article-title":"Prevalence and practice for rare diseases in primary care: a national cross-sectional study in the USA","volume":"9","author":"Jo","year":"2019","journal-title":"BMJ Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"220170","DOI":"10.1183\/20734735.0170-2022","article-title":"Eosinophilic granulomatosis with polyangiitis: case report and literature review","volume":"18","author":"Alam","year":"2022","journal-title":"Breathe"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.leukres.2012.12.016","article-title":"Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature","volume":"37","author":"Podjasek","year":"2013","journal-title":"Leuk Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg\u2013Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1568770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:20Z","timestamp":1750742540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1568770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":36,"alternative-id":["10.3389\/fmed.2025.1568770"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1568770","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1568770"}}